1.
Analysis of the proteomics and immunoreactivities of excretory-secretory antigens of Schistosoma japonicum adult worms
血吸虫成虫排泄分泌抗原的组成及免疫反应性分析
2.
Expression and Purification of Tp0751 Recombinant Protein of Treponema pallidum and Its Immunoresponse Analysis
苍白密螺旋体Tp0751黏附蛋白的表达、纯化及免疫反应性分析
3.
Cloning and expression of the Fae G gene of enterotoxigenic Escherichia coli K88 fimbrial subunit in Lactococcus lactis
ETEC粘附素蛋白亚基Fae G在乳酸乳球菌中的表达及免疫反应性分析
4.
Immune-function Analysis of Pigs with Dumbing Immune Response to CSF Vaccine
猪瘟疫苗免疫反应低下猪的免疫功能分析
5.
immunoreactive protein
免疫反应性蛋白，免疫活性蛋白（质）
6.
Analysis of adverse effects of allergen test and allergen-specific immunotherapy
变应原检测和特异性免疫治疗中不良反应的分析
7.
Stability Analysis for a Delayed Viral Infection Model with Lytic Immune Response
一类具有溶菌性免疫反应的时滞病毒感染模型的稳定性分析(英文)
8.
immunoreactive glucagon (IRG)
免疫反应性高血糖素
9.
Stability Analysis of Autoimmune Disease Model with Functional Response
考虑功能性反应的自体免疫疾病动力学模型分析
10.
Proteomic Analysis to Augmented Immune Responses in Mouse by Prime-and-Boost Immunization Strategy with HBsAg DNA and Protein Vaccine;
乙肝表面抗原DNA疫苗初免—蛋白疫苗加强免疫策略增强免疫反应的蛋白质组学分析
11.
Effect analysis on mother-foetus hypoimmunologic recognition recurrent spontaneous abortion use lymphocyte active immunity method
淋巴细胞主动免疫治疗母-胎免疫识别低下型反复性流产疗效分析
12.
Dynamical Analysis of HIV Infection Model with CTL Immune Response
CTL免疫反应的HIV感染模型的动力学分析
13.
Effects of Positive and Negative Emotion on Neuroendocrine and Immunity;
正负性情绪的神经内分泌和免疫反应研究进展
14.
The branch of immunology that deals with the molecular and genetic bases of the immune response.
免疫遗传学免疫学中研究免疫反应的细胞和基因基础的分支
15.
A Clinical Analysis of 31 Cases of Specific Immunotherapy on Allergic Rhinitis;
31例变应性鼻炎特异性免疫治疗的临床分析
16.
A Clinical Analysis of Specific Immunotherapy on Allergic Rhinitis
变应性鼻炎特异性免疫治疗的临床分析
17.
Unresponsiveness to an antigen that normally produces an immunological reaction.
免疫耐受性对一般会产生免疫性反应的抗原不作任何反应
18.
Specificity and Characterization of Immune Response to Plasmodium Falciparum Chimeric Protein 2.9 (PfCP-2.9) in Phase Ⅰ Trial;
PfCP-2.9重组恶性疟疾疫苗Ⅰ期临床试验免疫应答及特性分析